Sign In
Buy RYTM
$84.71
+0.360 (+0.427%)
At Close: Jun 03, 2026
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
10:07am, Wednesday, 03'rd Aug 2022 Benzinga
Gainers
MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Applied DNA Sciences, Inc. (NASDAQ: APDN) surged 296.9% to settle at $2
Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth Conference
08:00am, Wednesday, 03'rd Aug 2022
BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families liv
Why Rhythm Pharmaceuticals Stock Is Rocketing Higher Today
07:51pm, Tuesday, 02'nd Aug 2022 The Motley Fool
The biotech's second-quarter earnings report is a big hit with shareholders.
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
04:41pm, Tuesday, 02'nd Aug 2022 Benzinga
Gainers
AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 166% to $1.8801
Why Rhythm Pharmaceuticals Stock Is Rocketing Higher Today
03:51pm, Tuesday, 02'nd Aug 2022
The biotech's second-quarter earnings report is a big hit with shareholders.
Why U.S. Stocks Are Trading Lower; Job Openings Drop To This Level In June
02:34pm, Tuesday, 02'nd Aug 2022 Benzinga
U.S. stocks traded lower this morning, with the Dow Jones falling more than 250 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.87% to 32,511.89 while the NASDAQ fell 0.
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Lags Revenue Estimates
12:25pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of -12.66% and 58.13%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the
Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q2 2022 Results - Earnings Call Transcript
11:23am, Tuesday, 02'nd Aug 2022
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM ) Q2 2022 Results Earnings Conference Call August 2, 2022 8:00 AM ET Company Participants David Connolly - Investor Relations and Corporate Communications Dav
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Lags Revenue Estimates
09:50am, Tuesday, 02'nd Aug 2022
Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of -12.66% and 58.13%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the
Why Shares Of Rhythm Pharmaceuticals Are Soaring
10:48am, Wednesday, 20'th Jul 2022
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) shares are trading higher after the French National Agency for Medicines and Health Products Safety and Haute Autorité de santé granted pre-marketing auth
Rhythm (RYTM) Surges on Upbeat Data on Lead Product Candidate
01:51pm, Wednesday, 13'th Jul 2022
Rhythm Pharmaceuticals (RYTM) reports favorable data from a mid-stage study evaluating the efficacy of setmelanotide, its MC4R agonist, for treating hypothalamic obesity.
5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now?
11:03am, Friday, 17'th Jun 2022
Penny stocks are red hot right now if you know where to… The post 5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now? appeared first on Penny Stocks to Buy, Picks, News and Informa
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
05:11pm, Friday, 03'rd Jun 2022
Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way. The post 6 Biotech Stocks to Buy Now Ahead o
Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q1 2022 Results - Earnings Call Transcript
02:47pm, Tuesday, 03'rd May 2022
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM ) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants David Connolly - Investor Relations and Corporate Communications David Meeker -
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates
09:47am, Tuesday, 03'rd May 2022
Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of -7.14% and 38.86%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the
